openPR Logo
Press release

Metabolomics Diagnostics and Analytical Technologies Market Key Trends in terms of volume and value 2016-2020

12-23-2016 08:25 AM CET | Health & Medicine

Press release from: SA-BRC

Metabolomics Diagnostics and Analytical Technologies Market

Metabolomics is a nascent field of science that deals with the study of metabolites produced in the body. It provides insight on the chemical fingerprints of cellular processes through characterization of small molecules. The field of gene mutation and drug discovery s expected to have been benefited the most from this field of omics. However, along with this several other fields such as biofuels, nutrigenomics, agriculture, and food safety have also benefited from the technique. The metabolomics techniques have developed to become a key tool to investigate several aspects of human fluids and its contents. Metabolome which refers to a complete set of small molecule metabolites was identified and converted into one of the largest web database METLIN in 2005. By 2010, although research in metabolomics had started growing at a strong pace, the commercial aspect was facing significant technical challenges. There are two aspects to metabolomics: Metabolite Profiling which deals with the phenotypic characterization of an organism by non-invasive means and Metabolic Profiling, which deals with the use of spectroscopy to identify metabolites. The advent of metabolite biomarkers will have profound implication on the progress of diagnostics market in coming years.

The market for metabolomics is constituted of three parts, namely Instrumentation; which primarily deals with Gas-Chromatography, Mass Spectrometry (GC-MS), tandem mass spectrometry and NMR spectroscopy devices. The second commercial segment deals with the sale of diagnostic kits and reagents which constitute as consumables, the third commercial segment. Diagnostics market includes emerging companies such as Metabolon, which deals in the sale of biomarkers used to detect various cancers such as prostate cancer, bladder cancer, kidney cancer among others. The company estimates a yearly scope of performing over 20 million diagnostic tests which carves a potential market of $ 2.0 billion each year. Along with this there are several companies in the fray such as Tethys BioScience, which is in the process of commercializing a diabetes test called PreDx.

Click For Full Report And Request TOC@ http://www.sa-brc.com/Global-Metabolomics-Diagnostics-and-Analytical-Technologies-Market-Assessment--Forecast-2016---2020/upcomingdetail34

SA-BRC’s ongoing research estimates suggest that the metabolomics (diagnostics & tools) market is expected to be valued at around US$ 3.0 billion in 2014 although the potential addressable market is worth over US$ 5.5 billion. The growth of the metabolomics market exceeds a CAGR of 50% and thus can be expected to grow exponentially in the coming years. Currently North America and Europe constitute over 75% of the total market for metabolomics research equipment and consumables along with services. Asia is entering this field with major investors being China and Japan. North America has the largest research pipeline with studies happening in several areas of oncology and diabetes. Besides upcoming companies such as Metabolon and Tethys, other major players in the field are Thermo Fisher which is involved in providing software support along with research technologies such as spectroscopy technologies and Molecular Biometrics which is a supplier of proprietary biospectroscopy technologies for metabolomics. Other players are Human Metabolome Technologies, Metabomatrix and Genedata.

The main driver of metabolomics market is the cost to effectiveness comparison which is much better than any other method of biomarker detection. Even with these drivers, the market faces challenges such as lack of connection between other “omics” sciences such as genomics and proteomics. Research is still required to go a long way since an estimated 60% molecules of unknown nature are yet to be identified. But through all these challenges, the field is garnering more attention each day and the coming years will hold a key role for metabolomics in treating dreadful diseases. Since the diagnostics market is immature, the competitive landscape is tightly consolidated with top 5 players accounting for 90% of the total market. However, the data and analytical tools market that accounts for approximately 75% of the market scope is highly fragmented on a global level.

For More Research Reports@ http://www.sa-brc.com/Healthcare-IT/industry4

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolomics Diagnostics and Analytical Technologies Market Key Trends in terms of volume and value 2016-2020 here

News-ID: 400720 • Views: 431

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Metabolomics

Metabolomics Market Competition is Cutthroat over 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market - Global Regional Outlook 2017 - 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market Segmentation Analysis
A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR). Hitherto, these companies have relied upon innovation and product advancements for the growth of
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more
Metabolomics Market: Overview & Sector Analysis (2016 - 2024)
Biomarker discovery segment to be the largest share of the global metabolomics market The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into